Lung cancer pathogenesis, similar to many other cancers, is initiated by activation of oncogenes or inactivation of tumor suppressor genes, such as mutation of K-ras [6] or p53 [7], EGFR amplification [5], COX-2 overexpression [8], or loss of RAR-β expression [9]. This evidence concerns the gene EGFR and lung carcinoma.